<bill session="116" type="h" number="6049" updated="2022-02-08T23:17:37Z">
  <state datetime="2020-03-02">REFERRED</state>
  <status>
    <introduced datetime="2020-03-02"/>
  </status>
  <introduced datetime="2020-03-02"/>
  <titles>
    <title type="display">Medical Supply Chain Security Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain.</title>
    <title type="short" as="introduced">Medical Supply Chain Security Act</title>
  </titles>
  <sponsor bioguide_id="G000579"/>
  <cosponsors>
    <cosponsor bioguide_id="F000466" joined="2020-05-27"/>
    <cosponsor bioguide_id="G000576" joined="2020-04-28"/>
    <cosponsor bioguide_id="M001198" joined="2020-04-28"/>
    <cosponsor bioguide_id="M001194" joined="2020-06-15"/>
    <cosponsor bioguide_id="P000607" joined="2020-03-02"/>
  </cosponsors>
  <actions>
    <action datetime="2020-03-02">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-03-02" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="3343" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health information and medical records"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-07T20:57:48Z" status="Introduced in House">Medical Supply Chain Security Act

This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.</summary>
</bill>
